Overview
Anthony Boral is an Oncologist practicing medicine in Cambridge, Massachusetts.
Dr. Boral is highly rated in 1 condition, according to our data. His clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Gastrointestinal Stromal Tumor.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
38 Sidney St, Cambridge, MA 02139
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Jacobsen is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Anthony Boral
How do I make an appointment with Dr. Anthony Boral?
You can book an appointment with Dr. Anthony Boral by calling their office at 617-714-6697. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Anthony Boral a top-rated expert for Mast Cell Activation Syndrome (MCAS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anthony Boral is classified as an Advanced expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Anthony Boral specialize in?
While Dr. Anthony Boral is a Oncology, they have specific expertise in Mast Cell Activation Syndrome (MCAS), Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Anthony Boral participate in research or clinical trials?
Yes. Dr. Anthony Boral has published 9 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Dr. Anthony Boral's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mast Cell Activation Syndrome (MCAS)
- Experienced
- Gastrointestinal Stromal TumorDr. Boral isExperienced. Learn about Gastrointestinal Stromal Tumor.
- Lung CancerDr. Boral isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Boral isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).